Search results

A multi-technology decarbonisation project at The Christie NHS Foundation Trust has reduced its building energy carbon emissions by an estimated 1,000 tonnes a year (around 10%).

A granddad from Stockport is showing no signs of cancer nearly 6 years after he first started on the FLAIR clinical trial at The Christie NHS Foundation Trust, a specialist cancer centre in Manchester.

Researchers at The Christie NHS Foundation Trust and The University of Manchester are hoping to identify how to reduce the long-term side effects radiotherapy can cause for children and young people.

Patients with skin cancer are set to benefit from a new superficial treatment machine at The Christie that can deliver a type of low-energy radiotherapy.

As The Christie at Macclesfield celebrates its third anniversary, patients and staff have hailed a leap forward in cancer care and applauded recent innovations.

Last week, we hosted a team from the OECI (Organisation of European Cancer Institutes) for a peer review visit to The Christie as part of our re-accreditation process as a comprehensive cancer centre.

The Christie NHS Foundation Trust in Manchester is leading a groundbreaking clinical trial that could transform the treatment of glioblastoma, the most aggressive and deadly form of brain cancer.

Professor Joe Rafferty has been appointed as the new Chair of The Christie NHS Foundation Trust. He will take up his role on 1 May 2025.

Patients with both malignant and non-malignant haematologigical conditions in the Cheshire West and Chester area will now benefit from local access to the care and expertise of The Christie.

After more than 3 decades at The Christie, advanced practitioner Karen Johnson is preparing to retire this year. Her clinical expertise and patient-centred care are deeply valued by the oncology gynaecology team and by her patients.

A Christie cancer patient from Rochdale has been given the option to learn self-acupuncture to help with the side effects his medication is having.

We are issuing this statement to reassure all of our patients and staff that the quality of care provided at The Christie remains of the highest standard and to correct some misleading media reporting that has caused widespread concern and distress.  

As more people are diagnosed with cancer and more treatments are available to patients, The Christie has delivered a record number of chemotherapy and immunotherapy treatments in one 12-month period for the first time in its 125-year history.

Researchers at The Christie have classified all the genetic mutations related to a rare appendiceal cancer – pseudomyxoma peritonei (PMP) - for the first time ever.

More people than ever before are facing the dual diagnosis of cancer and dementia, which is why The Christie in Manchester provides tailored support for these vulnerable patients.

A ground-breaking model of cancer care developed at The Christie NHS Foundation Trust in Manchester is now at the centre of a national campaign to improve supportive oncology services across the UK.

Zara McCormick is celebrating more than 18 months of being free from bowel cancer after taking part in a clinical trial at The Christie NHS Foundation Trust, a specialist cancer centre in Manchester.

A pioneering service from Manchester's specialist cancer centre, The Christie, providing cancer treatments to patients in the comfort of their own home, has introduced a fully electric fleet of vehicles for nurses.

Suzanne Lagan achieved a significant personal and professional milestone, qualifying, via an apprenticeship route, as a fully registered diagnostic radiographer at Manchester’s specialist cancer centre, The Christie.

The Christie NHS Foundation Trust has appointed Amanda Oates and Dr Marisa Logan-Ward as non-executive directors to its board of directors. Both roles are for a 3-year period.